BNP Paribas Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.16M Sell
154,327
-197,303
-56% -$7.1M 0.01% 800
2026
Q1
$8.62M Buy
351,630
+46,569
+15% +$1.1M 0.01% 724
2025
Q4
$7.57M Buy
305,061
+304,650
+74,124% +$8.09M 0.01% 744
2025
Q3
$12K Hold
411
– – ﹤0.01% 1587
2025
Q2
$10K Buy
+411
New +$11.6K ﹤0.01% 1795

Other funds holding ASTH

BNP Paribas Asset Management's ASTH Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Astrana Health (ASTH) stake by 56% in Q2 2026, selling an estimated $7.1M and leaving 154,327 shares worth $7.16M. The position accounts for 0.01% of the portfolio, ranked #800.

BNP Paribas Asset Management first reported a position in ASTH in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.62M in Q1 2026. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • BNP Paribas Asset Management held 154,327 shares of Astrana Health worth $7.16M as of Q2 2026.
  • BNP Paribas Asset Management sold 197,303 Astrana Health shares in Q2 2026, an estimated $7.1M.
  • Astrana Health made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #800 holding.
  • BNP Paribas Asset Management first reported a position in Astrana Health in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Astrana Health position peaked at $8.62M in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.